Biopharmaceuticals and gene vectors opening new avenues in cancer immune therapy

Haider Sami; Manfred Ogris

doi:10.4155/tde-2016-0032

Biopharmaceuticals and gene vectors opening new avenues in cancer immune therapy

Haider Sami
, Manfred Ogris (Corresponding author)

Publications: Contribution to journal › Editorial › Peer Reviewed

Original language	English
Pages (from-to)	419-422
Number of pages	4
Journal	Therapeutic Delivery
Volume	7
Issue number	7
DOIs	https://doi.org/10.4155/tde-2016-0032
Publication status	Published - Jul 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Austrian Fields of Science 2012

301207 Pharmaceutical chemistry

Keywords

Journal Article
ANTIBODIES
cancer gene therapy
oncolytic virus
INTERLEUKIN-12
cancer
immune checkpoint inhibitors
PD-1
SIRP-ALPHA
VIRUSES
TUMOR-IMMUNOTHERAPY

Access to Document

10.4155/tde-2016-0032

Cite this

@article{13a5c578be6c4eecae434be16ea917b0,

title = "Biopharmaceuticals and gene vectors opening new avenues in cancer immune therapy",

keywords = "Journal Article, ANTIBODIES, cancer gene therapy, oncolytic virus, INTERLEUKIN-12, cancer, immune checkpoint inhibitors, PD-1, SIRP-ALPHA, VIRUSES, TUMOR-IMMUNOTHERAPY",

author = "Haider Sami and Manfred Ogris",

year = "2016",

month = jul,

doi = "10.4155/tde-2016-0032",

language = "English",

volume = "7",

pages = "419--422",

journal = "Therapeutic Delivery",

issn = "2041-5990",

number = "7",

}

TY - JOUR

T1 - Biopharmaceuticals and gene vectors opening new avenues in cancer immune therapy

AU - Sami, Haider

AU - Ogris, Manfred

PY - 2016/7

Y1 - 2016/7

KW - Journal Article

KW - ANTIBODIES

KW - cancer gene therapy

KW - oncolytic virus

KW - INTERLEUKIN-12

KW - cancer

KW - immune checkpoint inhibitors

KW - PD-1

KW - SIRP-ALPHA

KW - VIRUSES

KW - TUMOR-IMMUNOTHERAPY

UR - https://www.scopus.com/pages/publications/84978655880

U2 - 10.4155/tde-2016-0032

DO - 10.4155/tde-2016-0032

M3 - Editorial

C2 - 27403627

SN - 2041-5990

VL - 7

SP - 419

EP - 422

JO - Therapeutic Delivery

JF - Therapeutic Delivery

IS - 7

ER -

Biopharmaceuticals and gene vectors opening new avenues in cancer immune therapy

UN SDGs

Austrian Fields of Science 2012

Keywords

Access to Document

Other files and links

Cite this